Market Newsdesk

May 27, 2026 6:13 am

Ellomay Capital Reports Results for the Three Months Ended March 31, 2026

TEL-AVIV, Israel, May 27, 2026 (GLOBE NEWSWIRE) — Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, USA and Israel, today reported its unaudited interim consolidated financial results for the three month period ended March 31, 2026.

Financial Highlights

Total assets as of March 31, 2026 amounted to approximately €885.4 million, compared to total assets as of December 31, 2025 of approximately €843.5 million.
Revenues¹ for the three months ended March 31, 2026 were approximately €8.7 million, compared to revenues of approximately €8.9 million for the three months ended March 31, 2025.
Loss for the three months ended March 31, 2026 was approximately €12.2 million, compared to a profit of approximately €6.8 million for the three months ended March 31, 2025.
EBITDA for the three months ended March 31, 2026 was approximately €2.1 million, compared to EBITDA of approximately €2.9 million for the three months ended March 31, 2025. See below under “Use of Non-IFRS Financial Measures” for additional disclosure concerning EBITDA.
On May 10, 2026, the Company completed the sale of its indirect holdings in Ellomay Luzon Energy Infrastructures Ltd. (“Ellomay Luzon Energy”) for a purchase price of approximately NIS 560 million (approximately €164 million as of such date). Consequently, the Company’s share of profits of Ellomay Luzon Energy, which was an equity accounted investee, after elimination of intercompany transactions, was presented as discontinued operations and results from prior periods were adjusted accordingly.
In connection with such sale, the Company executed an early repayment of the Company’s Series E Secured Debentures, which were secured by a pledge on the Ellomay Luzon Energy shares. The principal of the Series E Secured Debentures was NIS 165 million (approximately €45.4 million) and the aggregate repayment amount was approximately NIS 170 million (approximately €46.8 million), which includes accrued interest and the early repayment fee.

___________________
¹ The revenues presented in the Company’s financial results included in this press release are based on IFRS and do not take into account the adjustments included in the Company’s investor presentation.

Financial
O
verview
for the
Three Months
Ended
March
31,
2026

Revenues were approximately €8.7 million for the three months ended March 31, 2026, compared to approximately €8.9 million for the three months ended March 31, 2025. The decrease in revenues mainly resulted from decreases in the electricity prices in Italy and Spain commencing 2025 and during the first quarter of 2026.
Operating expenses were approximately €5.1 million for the three months ended March 31, 2026, compared to approximately €4.6 million for the three months ended March 31, 2025. The increase in operating expenses mainly resulted from energy and feedstock costs in projects in the Netherlands, and expenses in connection with the Company’s 18 MW Italy and 38 MW Texas solar facilities that were connected to the grid during the second and third quarters of 2025.
Depreciation and amortization expenses were approximately €4.5 million for the three months ended March 31, 2026, compared to approximately €4.2 million for the three months ended March 31, 2025.
Project development costs were approximately €0.4 million for the three months ended March 31, 2026, compared to approximately €1 million for the three months ended March 31, 2025. The decrease in project development costs is mainly due to projects that reached “ready to build” (“RTB”) or “permission to operate” (“PTO”) status, which resulted in the commencement of capitalization of expenses related to such projects into fixed assets.
General and administrative expenses were approximately €2.5 million for the three months ended March 31, 2026, compared to approximately €1.7 million for the three months ended March 31, 2025. The increase in general and administrative expenses is mainly due to higher insurance and consulting expenses.
Other income was approximately €1.1 million for the three months ended March 31, 2026, compared to approximately €0.2 million for the three months ended March 31, 2025. The income during the three months ended March 31, 2026 mainly resulted from the recognition of a proportional share of deferred income related to tax credits in connection with three of the Company’s USA solar facilities. The other income recognized for three months ended March 31, 2025 is based on compensation received from insurance in connection with the fire near the Talasol and Ellomay Solar facilities in Spain.
Financing expenses, net, was approximately €8.2 million for the three months ended March 31, 2026, compared to financing income, net, of approximately €7.2 million for the three months ended March 31, 2025. The change in financing expenses, net, was mainly attributable to higher expenses resulting from exchange rate differences that amounted to approximately €2.9 million for the three months ended March 31, 2026, compared to income from exchange rate differences of approximately €10.7 million for the three months ended March 31, 2025, an aggregate change of approximately €13.6 million. The exchange rate differences were mainly recorded in connection with the New Israeli Shekel (“NIS”) cash and cash equivalents and the Company’s NIS denominated debentures and were caused by the 2.9% appreciation of the NIS against the euro during the three months ended March 31, 2026, compared to a 5.9% devaluation of the NIS against the euro during the three months ended March 31, 2025. The increase in financing expenses, net also resulted from an increase in interest expenses in connection with the Company’s debentures.
Taxes on income were approximately €1.6 million for the three months ended March 31, 2026, compared to a tax benefit of approximately €0.9 million for the three months ended March 31, 2025. The change is primarily attributable to deferred tax liability relating to the differences between the carrying amounts of the Texas solar facilities that were placed in service and their tax bases, as well as relating to the investment in Ellomay Luzon Energy, in light of the disposal of the investment in May 2026, subsequent to the balance sheet date.
Loss from continuing operations was approximately €12.5 million for the three months ended March 31, 2026, compared to profit from continuing operations of approximately €5.6 million for the three months ended March 31, 2025.
Profit from discontinued operations was approximately €0.3 million for the three months ended March 31, 2026, compared to approximately €1.2 million for the three months ended March 31, 2025. As noted above, the profit from discontinued operations reflects the Company’s share of profits of Ellomay Luzon Energy, an equity accounted investee that was sold on May 10, 2026. The decrease in the Company’s share of profits of equity accounted investee was mainly attributable to increased financing expenses recorded by Dorad Energy Ltd. (“Dorad”) due to the impact of the USD/NIS exchange rate fluctuations on deposits in USD and forward contracts and the reduced demand for electricity.
Loss for the three months ended March 31, 2026 was approximately €12.2 million, compared to a profit of approximately €6.8 million for the three months ended March 31, 2025.
Total other comprehensive income was approximately €5.9 million for the three months ended March 31, 2026, compared to total other comprehensive loss of approximately €4.9 million in the three months ended March 31, 2025. The change in total other comprehensive income (loss) primarily resulted from foreign currency translation adjustments due to the change in the NIS/euro exchange rate and from changes in fair value of cash flow hedges, including a material decrease in the fair value of the liability resulting from the financial power swap that covers approximately 80% of the output of the Talasol solar plant (the “Talasol PPA”). The Talasol PPA experienced a high volatility due to the substantial change in electricity prices in Europe. In accordance with hedge accounting standards, the changes in the Talasol PPA’s fair value are recorded in the Company’s shareholders’ equity through a hedging reserve and not through the accumulated deficit/retained earnings. The changes do not impact the Company’s consolidated net profit/loss or the Company’s consolidated cash flows.
Total comprehensive loss was approximately €6.3 million for the three months ended March 31, 2026, compared to total comprehensive income of approximately €1.9 million for the three months ended March 31, 2025.
EBITDA was approximately €2.1 million for the three months ended March 31, 2026, compared to approximately €2.9 million for the three months ended March 31, 2025.
Net cash used in operating activities was approximately €1.9 million for the three months ended March 31, 2026, compared to net cash generated from operating activities of approximately €0.3 million for the three months ended March 31, 2025. The change in net cash used in operating activities mainly resulted from lower income due to relatively low electricity prices and increased insurance and consultancy expenses.

CEO Review
for First Quarter of
202
6

In the first quarter of 2026
, the Company’s revenues amounted to approximately €
8.7
million,
compared to revenues of approximately €8.9
million in
the corresponding
quarter
last year.
The decline in
revenues
was primarily attributable to low
,
and at times negative
,
electricity prices in Spain and
Italy
during the first quarter of 2026. The
revaluation
of the NIS against the
e
uro resulted in finance expenses of approximately €4.8 million in the first quarter of 2026, compared to finance income of approximately €10.6 million resulting from the appreciation
of the
e
uro against the NIS in the corresponding quarter
last
year
.

During the first quarter of 2026, an agreement was signed for the sale of the Company’s 50% interest in
Ellomay
Luzon Energy Infrastructures Ltd., which holds a 33.75% interest in Dorad Energy Ltd., based on a Dorad valuation of NIS 4.4 billion. The transaction was completed in May 2026, and the Company received consideration of approximately NIS 560 million, a price reflecting a significant gain on the investment.

In Italy – 38 MW solar (51% owned in partnership with Clal) are fully operating. The construction work on additional 160 MW solar (51% owned in partnership with Clal) has begun and construction is progressing as planned and is expected to be finished by the end of 2026. The remainder of the portfolio developed by the Company (100% owned) is approximately 264 MW solar, of which 210 MW have reached RTB status as of the date hereof and the rest are expected to receive permits in the near future. These 264 MW are scheduled to begin construction in the last quarter of 2026. Out of 210 MW that are RTB, approximately 100 MW (2 projects) won the FER X tender that guarantees a 20-year electricity sale contract at high prices. The Company signed a power purchase agreement (“PPA”) with a leading European entity for the operating projects with an aggregate capacity of 38 MW and the Company intends to continue to execute PPAs for the remainder of the portfolio. The Company is examining the establishment of battery-based electricity storage facilities in northern Italy. As part of this review, a non-binding offer has been signed for the acquisition of a license for a 50 MW / peak per hour facility with 4 hours of storage, and the possibility of acquiring an additional license for a 100 MW / peak per hour facility with 4 hours of storage is also being considered.

In the USA – the construction of the first 4 projects (49 MW) has been completed, three of them were connected to the grid at the end of the first half of 2025 and the fourth project is currently being connected. The Company is constructing the Hillsboro project (14 MW solar), whose expected to complete construction and connection to the grid in September 2026. The Company is planning the construction of two additional projects of 14 MW each that will fall within the current tax benefit framework. There is a possibility of including two additional projects in the same area in the portfolio. The regulatory changes and the uncertainty regarding tariff rates do not allow the Company to provide a forecast beyond what has been said, but the assumption is that the Company will find a way to continue developing and increasing the portfolio in the near future.

In the Netherlands – the license to increase production at the GGOT facility was received. Licenses to increase production at the two additional facilities are in advanced stages. The new regulation for the obligation to blend green gas with fossil gas will commence according to the law in January 2027 (a delay of one year), but the targets for the first year have increased. Agreements have been signed for the sale of green certificates issued under the new regulation at a price of approximately €1 per certificate. The blending obligation is expected to significantly increase the profitability of operations in the Netherlands at current production capacity. Following receipt of the licenses to increase production capacities the Company plans to increase the production capacity from 16 million cubic meters of gas per year to around 24 million cubic meters of gas per year in the existing facilities. This increase is expected to lead to material increases in revenues and profits.

In Israel – at the end of December 2025, tunneling works resumed at the Manara pumped storage project. The tunneling works are progressing well at present. However, works on the upper and lower reservoir sites have halted due to the ongoing war-related events in northern Israel. These works are expected to resume shortly, subject to security conditions. The Company is in negotiations with the Israeli Electricity Authority for compensation for delays and war damage to the Manara project.

In Spain – the Company is operating the existing solar portfolio (335 MWh). The development activity in Spain focuses on energy storage in batteries, whereby the process for obtaining license for Ellomay Solar (28 MWp for two hours of battery storage) is in advanced stages and is expected to be received in the coming months. In addition, the Company is advancing a battery storage project for Talasol (210 MWp with 2 hours of storage). The high volatility in electricity prices in Spain stems from an excess of renewable energy during the transition seasons and causes damage to the stability of the grid. The solution to this problem is a significant increase in storage capacity, which is currently at very low levels in Spain.

Use of N
on
-IFRS Financial Measures

EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company’s operating performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company’s commitments, including capital expenditures and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measure presented by other companies. The Company’s EBITDA may not be indicative of the Company’s historic operating results; nor is it meant to be predictive of potential future results. The Company uses this measure internally as performance measure and believes that when this measure is combined with IFRS measure it add useful information concerning the Company’s operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 16 of this press release.

About
Ellomay
Capital Ltd.

Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol “ELLO”. Since 2009, Ellomay focuses its business in the renewable energy and power sectors in Europe, USA and Israel.

To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy, Spain, the Netherlands and Texas, USA, including:

Approximately 335.9 MW of operating solar power plants in Spain (including a 300 MW solar plant in owned by Talasol, which is 51% owned by the Company) and 51% of approximately 38 MW of operating solar power plants in Italy;
Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million Nm3 per year, respectively;
83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel;
51% of solar projects in Italy with an aggregate capacity of 160 MW that are under construction;
Solar projects in Italy with an aggregate capacity of 210 MW that have reached “ready to build” status; and
Solar projects in the Dallas Metropolitan area, Texas, USA with an aggregate capacity of approximately 38 MW that are connected to the grid, 11 MW that are currently in the test run phase prior to commercial operation and 14 MW that are under construction.

For more information about Ellomay, visit http://www.ellomay.com.

Information Relating to Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company’s management. All statements, other than statements of historical facts, included in this press release regarding the Company’s plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words “estimate,” “project,” “intend,” “expect,” “believe” and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company’s forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company’s forward-looking statements, including changes in electricity prices and demand, regulatory changes increases in interest rates and inflation, changes in the supply and prices of resources required for the operation of the Company’s facilities (such as waste and natural gas) and in the price of oil, the impact of the war and hostilities in Israel and Gaza and between Israel and Iran, the impact of the continued military conflict between Russia and Ukraine, technical and other disruptions in the operations or construction of the power plants owned by the Company, inability to obtain the financing required for the development and construction of projects, increases in interest rates and inflation, changes in exchange rates, delays in development, construction, or commencement of operation of the projects under development, failure to obtain permits – whether within the set time frame or at all, climate change, and general market, political and economic conditions in the countries in which the Company operates, including Israel, Spain, Italy and the United States. and general market, political and economic conditions in the countries in which the Company operates, including Israel, Spain, Italy and the United States. These and other risks and uncertainties associated with the Company’s business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Kalia Rubenbach (Weintraub)
CFO
Tel: +972 (3) 797-1111
Email: [email protected]

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Statements of Financial Position

March 31,

December 31,

March 31,

2026

2025

2026

Unaudited

Audited

Unaudited

€ in thousands

Convenience Translation
into US$ in thousands*

Assets

Current assets:

Cash and cash equivalents

83,697

87,614

96,152

Restricted cash

20,458

656

23,502

Intangible asset from green certificates

501

576

Trade and revenue receivables

8,460

7,236

9,719

Other receivables

14,479

14,918

16,634

Derivatives asset short-term

4,873

3,743

5,598

Assets of disposal groups classified as held for sale

61,633

–

70,805

194,101

114,196

222,986

Non-current assets

Investment in equity accounted investee

–

59,542

–

Fixed assets

585,436

566,876

672,558

Right-of-use asset

45,223

44,386

51,953

Restricted cash and deposits

15,987

16,071

18,366

Deferred tax

11,465

11,914

13,171

Long-term receivables

18,811

18,097

21,610

Derivatives

14,392

12,433

16,534

691,314

729,319

794,192

Total assets

885,415

843,515

1,017,178

Liabilities and Equity

Current liabilities

Current maturities of long-term bank loans

23,354

17,235

26,829

Current maturities of other long-term loans

14,939

3,666

17,162

Current maturities of debentures

66,743

39,803

76,675

Trade payables

5,371

6,719

6,170

Other payables

20,971

17,145

24,089

Derivatives

463

675

532

Current maturities of lease liabilities

920

844

1,057

Warrants

5,618

5,929

6,454

138,379

92,016

158,968

Non-current liabilities

Long-term lease liabilities

36,271

35,491

41,670

Long-term bank loans

299,530

272,388

344,105

Other long-term loans

61,810

58,457

71,008

Debentures

176,739

209,374

203,040

Deferred tax

5,354

3,170

6,151

Other long-term liabilities

8,465

6,179

9,725

Derivatives

–

1,300

–

588,169

586,359

675,699

Total liabilities

726,547

678,375

834,667

Equity

Share capital

28,008

28,002

32,176

Share premium

96,603

96,585

110,979

Treasury shares

(1,736

)

(1,736

)

(1,994

)

Transaction reserve with non-controlling Interests

14,763

14,757

16,960

Reserves

20,884

16,674

23,993

Accumulated deficit

(24,137

)

(13,694

)

(27,729

)

Total equity attributed to shareholders of the Company

134,385

140,588

154,385

Non-controlling interest

24,483

24,552

28,126

Total equity

158,868

165,140

182,511

Total liabilities and equity

885,415

843,515

1,017,178

* Convenience translation into US$ (exchange rate as at March 31, 2026: euro 1 = US$ 1.149)


Ellomay Capital Ltd. and its Subsidiaries
Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income (Loss)
	For the three months ended March 31,						For the year ended December 31,			For the three months ended March 31,
	2026			2025			2025			2026
	Unaudited						Audited			Unaudited
	€ in thousands (except per share data)									Convenience Translation into US$*
Revenues		8,665			8,860			42,827			9,954
Operating expenses		(5,077	)		(4,627	)		(19,408	)		(5,833	)
Depreciation and amortization expenses		(4,516	)		(4,238	)		(16,481	)		(5,188	)
Gross profit (loss)		(928	)		(5	)		6,938			(1,067	)

Project development costs		(375	)		(1,045	)		(2,649	)		(431	)
General and administrative expenses		(2,475	)		(1,662	)		(6,369	)		(2,843	)
Other income		1,080			198			3,599			1,241
Operating profit (loss)		(2,698	)		(2,514	)		1,519			(3,100	)

Financing income		616			11,483			2,876			708
Financing income (expenses) in connection with derivatives and warrants, net		493			(376	)		(3,917	)		566
Financing expenses in connection with project finance		(1,430	)		(1,375	)		(6,612	)		(1,643	)
Financing expenses in connection with debentures		(3,951	)		(1,741	)		(8,316	)		(4,539	)
Interest expenses on minority shareholder loan		(735	)		(476	)		(2,047	)		(844	)
Other financing expenses		(3,213	)		(294	)		(9,342	)		(3,691	)
Financing income (expenses), net		(8,220	)		7,221			(27,358	)		(9,443	)
Profit (loss) before taxes on income		(10,918	)		4,707			(25,839	)		(12,543	)
Tax benefit (taxes on income)		(1,600	)		922			2,528			(1,838	)
Profit (loss) from continuing operations		(12,518	)		5,629			(23,311	)		(14,381	)
Profit from discontinued operation (net of tax)		298			1,189			16,930			342
Profit (loss) for the period		(12,220	)		6,818			(6,381	)		(14,039	)
Profit (loss) attributable to:
Owners of the Company		(10,443	)		7,994			(2,133	)		(11,996	)
Non-controlling interests		(1,777	)		(1,176	)		(4,248	)		(2,043	)
Profit (loss) for the period		(12,220	)		6,818			(6,381	)		(14,039	)

Other comprehensive income (loss) items
That after initial recognition in comprehensive income were or will be transferred to profit or loss:
Foreign currency translation differences for foreign operations		2,502			(9,538	)		2,517			2,874
Effective portion of change in fair value of cash flow hedges		4,084			4,264			2,546			4,691
Net change in fair value of cash flow hedges transferred to profit or loss		(668	)		337			(2,734	)		(768	)
Total other comprehensive income (loss)		5,918			(4,937	)		2,329			6,797

Total other comprehensive income (loss) attributable to:
Owners of the Company		4,210			(6,957	)		2,336			4,836
Non-controlling interests		1,708			2,020			(7	)		1,961
Total other comprehensive income (loss)		5,918			(4,937	)		2,329			6,797
Total comprehensive income (loss) for the period		(6,302	)		1,881			(4,052	)		(7,242	)

Total comprehensive income (loss) for the period attributable to:
Owners of the Company		(6,233	)		1,037			203			(7,160	)
Non-controlling interests		(69	)		844			(4,255	)		(82	)
Total comprehensive income (loss) for the period		(6,302	)		1,881			(4,052	)		(7,242	)

* Convenience translation into US$ (exchange rate as at March 31, 2026: euro 1 = US$ 1.149)


Ellomay Capital Ltd. and its Subsidiaries
Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income (Loss) (cont’d)
	For the three months ended March 31,					For the year ended December 31,			For the three months ended March 31,
	2026			2025		2025			2026
	Unaudited					Audited			Unaudited
	€ in thousands (except per share data)								Convenience Translation into US$*

Basic profit (loss) per share		(0.76	)		0.62		(0.16	)		(0.87	)
Diluted profit (loss) per share		(0.76	)		0.62		(0.16	)		(0.87	)

Basic profit (loss) per share continuing operations		(0.78	)		0.53		(1.44	)		(0.89	)
Diluted profit (loss) per share continuing operations		(0.78	)		0.53		(1.44	)		(0.89	)

Basic profit per share discontinued operation		0.02			0.09		1.28			0.02
Diluted profit per share discontinued operation		0.02			0.09		1.28			0.02

* Convenience translation into US$ (exchange rate as at March 31, 2026: euro 1 = US$ 1.149)

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Changes in Equity

Attributable to shareholders of the Company

Non-
controlling
interests

Total
Equity

Share
capital

Share
premium

Accumulated
deficit

Treasury
shares

Translation

reserve from
foreign

operations

Hedging
reserve

Transaction
reserve with
non-controlling
interests

Total

€in thousands

For the three months

ended March 31, 2026 (unaudited):

Balance as at January 1, 2026

28,002

96,585

(13,694

)

(1,736

)

10,935

5,739

14,757

140,588

24,552

165,140

Loss for the period

–

(10,443

)

–

(10,443

)

(1,777

)

(12,220

)

Other comprehensive income for the period

–

2,412

1,798

–

4,210

1,708

5,918

Total comprehensive income (loss) for the period

–

(10,443

)

–

2,412

1,798

(6,233

)

(69

)

(6,302

)

Transactions with owners of the Company, recognized directly in equity:

Proceeds from transactions with non-controlling interests

–

Options exercise

–

Balance as at March 31, 2026

28,008

96,603

(24,137

)

(1,736

)

13,347

7,537

14,763

134,385

24,483

158,868

For the three months

ended March 31, 2025 (unaudited):

Balance as at January 1, 2025

25,613

86,271

(11,561

)

(1,736

)

8,446

5,892

5,697

118,622

10,663

129,285

Loss for the period

–

7,994

–

7,994

(1,176

)

6,818

Other comprehensive income (loss) for the period

–

(9,329

)

2,372

–

(6,957

)

2,020

(4,937

)

Total comprehensive income (loss) for the period

–

7,994

–

(9,329

)

2,372

–

1,037

844

1,881

Transactions with owners of the Company, recognized directly in equity:

Share-based payments

–

Balance as at March 31, 2025

25,613

86,275

(3,567

)

(1,736

)

(883

)

8,264

5,697

119,663

11,507

131,170


Ellomay Capital Ltd. and its Subsidiaries
Condensed Consolidated Interim Statements of Changes in Equity (cont’d)
					Attributable to shareholders of the Company																Non- controlling interests			Total Equity
	Share capital		Share premium		Accumulated deficit			Treasury shares			Translation reserve from foreign operations		Hedging reserve			Transaction reserve with non-controlling interests		Total
	€ in thousands
For the year ended
December 31, 2025 (audited):
Balance as at January 1, 2025		25,613		86,271		(11,561	)		(1,736	)		8,446		5,892			5,697		118,622			10,663			129,285
Loss for the year		–		–		(2,133	)		–			–		–			–		(2,133	)		(4,248	)		(6,381	)
Other comprehensive income (loss) for the year		–		–		–			–			2,489		(153	)		–		2,336			(7	)		2,329
Total comprehensive income (loss) for the year		–		–		(2,133	)		–			2,489		(153	)		–		203			(4,255	)		(4,052	)
Transactions with owners of the Company, recognized directly in equity:
Sale of shares in subsidiaries from non-controlling interests		–		–		–			–			–		–			9,060		9,060			16,997			26,057
Options exercise		7		17		–			–			–		–			–		24			–			24
Issuance of ordinary shares		2,382		10,281		–			–			–		–			–		12,663			–			12,663
Issuance of capital note to non-controlling interests		–		–		–			–			–		–			–		–			1,147			1,147
Share-based payments		–		16		–			–			–		–			–		16			–			16
Balance as at December 31, 2025		28,002		96,585		(13,694	)		(1,736	)		10,935		5,739			14,757		140,588			24,552			165,140

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Changes in Equity (cont’d)

Attributable to shareholders of the Company

Non-
controlling
interests

Total
Equity

Share
capital

Share
premium

Accumulated
deficit

Treasury
shares

Translation
reserve from
foreign
operations

Hedging
reserve

Transaction
reserve with
non-controlling
interests

Total

Convenience translation into US$ (exchange rate as at March 31, 2026: euro 1 = US$ 1.149)

For the three months

ended March 31, 2026 (unaudited):

Balance as at January 1, 2026

32,169

110,958

(15,733

)

(1,994

)

12,563

6,594

16,953

161,510

28,208

189,717

Loss for the period

–

(11,996

)

–

(11,996

)

(2,043

)

(14,039

)

Other comprehensive income for the period

–

2,771

2,065

–

4,836

1,961

6,797

Total comprehensive income (loss) for the period

–

(11,996

)

–

2,771

2,065

–

(7,160

)

(82

)

(7,242

)

Transactions with owners of the Company, recognized directly in equity:

Proceeds from transactions with non-controlling interests

–

Options exercise

–

Balance as at March 31, 2026

32,176

110,979

(27,729

)

(1,994

)

15,334

8,659

16,960

154,385

28,126

182,511


Ellomay Capital Ltd. and its Subsidiaries
Condensed Consolidated Interim Statements of Cash Flow
	For the three months ended March 31,						For the year ended December 31,			For the three months ended March 31,
	2026			2025			2025			2026
	Unaudited						Audited			Unaudited
	€in thousands									Convenience Translation into US$*

Cash flows generated from operating activities
Profit (loss) for the period		(12,220	)		6,818			(6,381	)		(14,039	)
Adjustments for:
Financing expenses (income), net		8,220			(7,221	)		27,358			9,442
Loss from settlement of derivatives contract		–			–			424			–
Depreciation and amortization expenses		4,515			4,238			16,481			5,187
Share-based payment transactions		–			4			16			–
Profit from discontinued operation (net of tax)		(298	)		(1,189	)		(16,930	)		(342	)
Change in trade receivables and other receivables		(3,811	)		6,178			5,883			(4,378	)
Change in other assets		–			(496	)		(713	)		–
Change in trade payables		(100	)		1,267			551			(115	)
Change in other payables		3,275			(5,358	)		(5,832	)		3,762
Tax benefit		1,600			(922	)		(2,528	)		1,838
Income taxes paid		(605	)		–			(583	)		(695	)
Interest received		709			351			2,160			813
Interest paid		(3,229	)		(3,408	)		(17,470	)		(3,709	)
		10,276			(6,556	)		8,817			11,803
Net cash generated from (used in) operating activities		(1,944	)		262			2,436			(2,236	)

Cash flows generated from investing activities
Acquisition of fixed assets		(11,215	)		(18,550	)		(97,828	)		(12,884	)
Interest paid capitalized to fixed assets		(974	)		(876	)		(4,052	)		(1,119	)
Advances on account of investments		–			–			547			–
Proceed from (investment in) restricted cash, net		(19,726	)		1,307			1,584			(22,662	)
Proceeds from investment in short-term deposits		–			(39,132	)		–			–
Net cash used in investing activities		(31,915	)		(57,251	)		(99,749	)		(36,665	)

Cash flows generated from financing activities
Proceeds from exercise of warrants		–			–			24			–
Cost associated with long-term loans		(703	)		(658	)		(4,575	)		(808	)
Proceeds from issuance of shares		–			–			12,663			–
Options exercise		24			–			–			28
Proceeds from transactions with non-controlling interests		6			–			–			7
Proceeds from minority partners in the Italian solar portfolio		–			–			51,458			–
Payment of principal of lease liabilities		(306	)		(372	)		(1,548	)		(352	)
Proceeds from short-term loans		17,453			–			–			20,050
Proceeds from long-term loans		27,808			306			51,681			31,947
Repayment of long-term loans		(1,810	)		(1,792	)		(35,414	)		(2,079	)
Repayment of debentures		(15,314	)		–			(35,691	)		(17,593	)
Proceeds from issuance of debentures, net		–			56,729			91,181			–
Proceeds from the sale of tax credits		3,981			–			10,160			4,573
Proceeds from issuance of warrants		–			–			475			–
Net cash generated from financing activities		31,139			54,213			140,414			35,773

Effect of exchange rate fluctuations on cash and cash equivalents		(1,197	)		(3,210	)		3,379			(1,374	)
Increase (decrease) in cash and cash equivalents		(3,917	)		(5,986	)		46,480			(4,500	)
Cash and cash equivalents at the beginning of year		87,614			41,134			41,134			100,652
Cash and cash equivalents at the end of the period		83,697			35,148			87,614			96,152

* Convenience translation into US$ (exchange rate as at March 31, 2026: euro 1 = US$ 1.149)

Ellomay Capital Ltd. and its Subsidiaries

Operating Segments

Italy

Spain

USA

Netherlands

Israel

Total

Subsidized

28 MV

reportable

Total

Solar

Plants

Solar

Talasol

Solar

Biogas

Dorad
¹

Manara

segments

Reconciliations

consolidated

For the three months ended March 31, 2026

€in thousands

Revenues

773

776

143

2,683

268

4,022

15,195

–

23,860

(15,195

)

8,665

Operating expenses

(171

)

(114

)

(172

)

(993

)

(74

)

(3,552

)

(11,732

)

–

(16,808

)

11,731

(5,077

)

Depreciation expenses

(447

)

(230

)

(253

)

(2,899

)

(402

)

(261

)

(1,454

)

–

(5,946

)

1,430

(4,516

)

Gross profit (loss)

155

432

(282

)

(1,209

)

(208

)

209

2,009

–

1,106

(2,034

)

(928

)

Project development costs

(375

)

General and administrative expenses

(2,475

)

Other income, net

1,080

Operating profit

(2,698

)

Financing income

616

Financing income in connection
with derivatives and warrants, net

493

Financing expenses in connection with projects finance

(1,430

)

Financing expenses in connection with debentures

(3,951

)

Interest expenses on minority shareholder loan

(735

)

Other financing expenses

(3,213

)

Financing expenses, net

(8,220

)

Loss before taxes on income

(10,918

)

Taxes on income

(1,600

)

Loss from continuing operations

(12,518

)

Profit from discontinued operation (net of tax)

298

Segment assets as at March 31, 2026

206,827

13,134

18,019

210,883

82,786

32,488

109,336

212,155

885,628

(213

)

885,415

^{_________________________________________}

¹Asset held for sale in connection with sale of Ellomay Luzon Energy.

Ellomay Capital Ltd. and its Subsidiaries

Reconciliation of Profit (Loss) to EBITDA

For the three months
ended March 31,

For the year
ended
December 31,

For the three months
ended March 31,

2026

2025

2026

€ in thousands

Convenience
Translation into US$*

Net profit (loss) for the period

(12,220

)

6,818

(6,381

)

(14,039

)

Financing expenses (income), net

8,220

(7,221

)

27,358

9,443

Taxes on income (tax benefit)

1,600

(922

)

(2,528

)

1,838

Depreciation and amortization expenses

4,516

4,238

16,481

5,188

EBITDA

2,116

2,913

34,930

2,430

* Convenience translation into US$ (exchange rate as at March 31, 2026: euro 1 = US$ 1.149)

Ellomay Capital Ltd. and its Subsidiaries

Information for the Company’s Debenture Holders

Financial Covenants

Pursuant to the Deeds of Trust governing the Company’s Series C, Series D, Series E, Series F and Series G Debentures (together, the “Debentures”), the Company is required to maintain certain financial covenants. For more information, see Items 4.A and 5.B of the Company’s Annual Report on Form 20-F submitted to the Securities and Exchange Commission dated April 30, 2026, and below.

Net Financial Debt

As of March 31, 2026, the Company’s Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company’s Debentures), was approximately €165.2 million (consisting of approximately €405.2² million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €248.9³ million in connection with (i) the Series D Convertible Debentures issuance (in February 2021), (ii) the Series E Secured Debentures issuance (in February 2023), (iii) the Series F Debentures issuance (in January, April, August and November 2024) and (iv) the Series G Debentures issuance (in February and December 2025)), net of approximately €83.7 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €405.2⁴ million of project finance and related hedging transactions of the Company’s subsidiaries).

Ellomay Capital Ltd. and its Subsidiaries

Information for the Company’s Debenture Holders (cont’d)

Information for the Company’s Series D Debenture Holders

The Deed of Trust governing the Company’s Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of March 31, 2026, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series D Deed of Trust) was approximately €145.5 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 53.2%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA⁵ was 4.8.

The following is a reconciliation between the Company’s profit and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended March 31, 2026:

	For the four-quarter period ended March 31, 2026
	Unaudited
	€ in thousands
Loss for the period		(25,419	)
Financing expenses, net		42,799
Tax benefit		(6	)
Depreciation and amortization expenses		16,759
Share based payments		12
Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters⁶		187
Adjusted EBITDA as defined the Series D Deed of Trust		34,332

Ellomay Capital Ltd. and its Subsidiaries

Information for the Company’s Debenture Holders (cont’d)

Information for the Company’s Series F Debenture Holders

The Deed of Trust governing the Company’s Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of March 31, 2026, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series D Deed of Trust) was approximately €144.8 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 53.4%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA⁷ was 4.8.

The following is a reconciliation between the Company’s profit and the Adjusted EBITDA (as defined in the Series F Deed of Trust) for the four-quarter period ended March 31, 2026:

	For the four-quarter period ended March 31, 2026
	Unaudited
	€ in thousands
Loss for the period		(25,419	)
Financing expenses, net		42,799
Tax benefit		(6	)
Depreciation and amortization expenses		16,759
Share based payments		12
Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters⁸		187
Adjusted EBITDA as defined the Series F Deed of Trust		34,332

Ellomay Capital Ltd. and its Subsidiaries

Information for the Company’s Debenture Holders (cont’d)

Information for the Company’s Series G Debenture Holders

The Deed of Trust governing the Company’s Series F Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series F Deed of Trust is a cause for immediate repayment. As of March 31, 2026, the Company was in compliance with the financial covenants set forth in the Series F Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series F Deed of Trust) was approximately €144.8 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 53.4%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA⁹ was 4.8.

The following is a reconciliation between the Company’s profit and the Adjusted EBITDA (as defined in the Series G Deed of Trust) for the four-quarter period ended March 31, 2026:

	For the four-quarter period ended March 31, 2026
	Unaudited
	€ in thousands
Loss for the period		(25,419	)
Financing expenses, net		42,799
Tax benefit		(6	)
Depreciation and amortization expenses		16,759
Share based payments		12
Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters¹⁰		187
Adjusted EBITDA as defined the Series G Deed of Trust		34,332

^{_____________________________________________}

² The amount of short-term and long-term debt from banks and other interest-bearing financial obligations provided above, includes an amount of approximately €5.5 million costs associated with such debt, which was capitalized and therefore offset from the debt amount that is recorded in the Company’s balance sheet.

³ The amount of the debentures provided above includes an amount of approximately €3.9 million associated costs, which was capitalized and discount or premium and therefore offset from the debentures amount that is recorded in the Company’s balance sheet. This amount also includes the accrued interest as at March 31, 2026 in the amount of approximately €1.5 million.

⁴ The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders’ loans to the project companies).

⁵ The term “Adjusted EBITDA” is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of NON-IFRS Financial Measures.”

⁶ The adjustment is based on the results of solar plants in the USA that were connected to the grid and commenced delivery of electricity to the grid during the four quarters preceding March 31, 2026.

⁷ The term “Adjusted EBITDA” is defined in the Series F Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series F Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series F Deed of Trust). The Series F Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series F Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of Non-IFRS Financial Measures.”

⁸ The adjustment is based on the results of solar plants in the USA that were connected to the grid and commenced delivery of electricity to the grid during the four quarters preceding March 31, 2026.

⁹ The term “Adjusted EBITDA” is defined in the Series G Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series G Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series G Deed of Trust). The Series G Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series G Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of Non-IFRS Financial Measures.”

¹⁰ The adjustment is based on the results of solar plants in the USA that were connected to the grid and commenced delivery of electricity to the grid during the four quarters preceding March 31, 2026.

May 27, 2026 6:11 am

INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Discover Investors Who Received Capital One (NYSE: COF) Shares in Connection with Capital One’s Acquisition of Discover in May 2025 to Contact the Firm

SAN FRANCISCO, May 27, 2026 (GLOBE NEWSWIRE) — Girard Sharp LLP, a national investment, securities, and consumer class action firm, is investigating potential securities claims on behalf of former Discover Financial Services (“Discover”) investors who received shares of Capital One Financial Corporation (“Capital One” or the “Company”) in connection with Capital One’s acquisition of Discover on May 18, 2025 (“Merger”).

CAPITAL ONE STOCK DROPS AFTER MAY MERGER

Capital One is a McLean, Virginia–based bank holding company that offers a comprehensive suite of financial services, including consumer and commercial banking, auto loans, and rewards credit cards. The Company states, “Today, we are one of the most widely recognized brands in banking — serving more than 100 million customers across a diverse set of businesses.” Since the closing of the Merger, the Company’s stock price has declined in value.

If you are a former Discover investor with losses, please

fill out this form

, email

[email protected]

, or call (866) 981-4800 for a free consultation.

Why Girard Sharp?

Girard Sharp represents investors, consumers, and institutions in class actions and other complex litigation nationwide. We recently obtained a $36.5 million securities settlement against Maxar Technologies, a space imagery company, after its share price collapsed following its acquisition of DigitalGlobe. Our attorneys have obtained multimillion-dollar recoveries for victims of unfair and deceptive practices in antitrust, financial fraud, and consumer protection matters against some of the country’s largest corporations, including Raymond James, John Hancock, and Sears. Girard Sharp has earned top-tier rankings from U.S. News and World Report for Securities and Class Action Litigation and has been repeatedly selected as an Elite Trial Lawyers finalist by the National Law Journal.

Contact
Girard Sharp LLP
(866) 981-4800
[email protected]
[email protected]
www.girardsharp.com

May 27, 2026 6:09 am

Enerflex Ltd. Publishes 2026 Investor Update Presentation

CALGARY, Alberta, May 27, 2026 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) has published its 2026 Investor Update presentation outlining the Company’s outlook, strategic priorities and financial and capital allocation framework. A copy of the presentation is available on Enerflex’s website at www.enerflex.com.

Enerflex will host a virtual Investor Update beginning today at 8:00 am MT (10:00am ET). The Investor Update will include a formal presentation led by Enerflex’s President and CEO, Paul Mahoney, with a question-and-answer period to follow.

Investor Update Highlights:

Clear strategy focused on operational execution and disciplined growth: Enerflex aims to “compete intentionally and improve relentlessly,” prioritizing operational excellence, the highest value growth opportunities in markets where we can win, and disciplined capital allocation to drive value creation for shareholders.
Exposure to attractive, growing end markets: Enerflex competes in a US$20B+ global market that is forecasted to grow at a CAGR of ~6% through 2030. End market growth is supported by increasing natural gas production, LNG exports, and power generation demand (including data centers) across North America, LATAM, and the Middle East.
Strong, resilient business model with recurring revenue: Approximately 65% of our adjusted gross margin is generated from recurring sources, supported by Enerflex’s integrated equipment, infrastructure, and services platform across core global markets.
Improving financial performance and disciplined capital allocation: The Company’s objective is to increase each of adjusted EBITDA margin, cash conversion ratio and ROCE by 200+ bps on a full cycle basis through operational excellence, targeted growth and disciplined capital allocation.

Registration for the Virtual Investor Update can be completed using the following link: https://edge.media-server.com/mmc/p/eyz29mbq. Participants can join by webcast to follow along with the presentation. Questions can be submitted via the webcast or asked on the dial-in:

Dial-in numbers: https://register-conf.media-server.com/register/BI8e02cded3fae4a3dbb8d89234ae4be38.

Shortly after the live webcast, an archived version of the Investor Update will be available on Enerflex’s website.

ADVISORY REGARDING FORWARD-LOOKING INFORMATION

This news release contains “forward-looking information” within the meaning of applicable Canadian securities laws and “forward-looking statements” (and together with “forward-looking information”, “FLI”) within the meaning of the safe harbor provisions of the US Private Securities Litigation Reform Act of 1995. In particular, this news release includes (without limitation) FLI pertaining to the ability of the Company to increase each of adjusted EBITDA margin, cash conversion ratio and ROCE by 200+ bps and the timing associated therewith, if at all.

FLI are not guarantees of future performance and involve a number of risks and uncertainties. The actual results, performance, or achievements of Enerflex could differ and such differences could be material from those expressed in, or implied by, the FLI. The principal risks, uncertainties and other factors affecting Enerflex and its business are identified under the heading “Risk Factors” in: (i) Enerflex’s Annual Information Form for the year ended December 31, 2025, dated February 25, 2026; and (ii) in other filings with Canadian securities regulators and the SEC, copies of which are available under the electronic profile of the Company on SEDAR+ and EDGAR at www.sedarplus.ca and www.sec.gov/edgar, respectively. The FLI included in this news release are made as of the date of this news release and are based on the information available to the Company at such time and, other than as required by law, Enerflex disclaims any intention or obligation to update or revise any FLI, whether as a result of new information, future events, or otherwise. This news release and its contents should not be construed, under any circumstances, as investment, tax, or legal advice.

ABOUT ENERFLEX

Enerflex is a leading provider of modular natural gas, power technology and treated water solutions, delivering value through disciplined execution and a deliberate approach to where we compete. Our customer-focused delivery model supports operational excellence, innovation, and scalability across our global footprint with a focus on creating long-term shareholder value.

With over 4,400 engineers, manufacturers, technicians, professionals, and innovators, Enerflex is bound together by a shared vision: Transforming Energy for a Sustainable Future. The Company remains committed to the future of natural gas and the critical role it plays, while focused on sustainability offerings to support the world’s energy needs.

Enerflex’s common shares trade on the Toronto Stock Exchange under the symbol “EFX” and on the New York Stock Exchange under the symbol “EFXT”. For more information about Enerflex, visit www.enerflex.com.

For investor and media enquiries, contact:

Paul Mahoney
President and Chief Executive Officer
E-mail: [email protected]

Preet S. Dhindsa
Senior Vice President and Chief Financial Officer
E-mail: [email protected]

Jeff Fetterly
Vice President, Corporate Development and Capital Markets
E-mail: [email protected]

May 27, 2026 6:07 am

INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Investors of Blue Owl Capital Corp. III (NYSE: OBDE) Who Received Shares of Blue Owl Capital Corp. (NYSE: OBDC), and Former Investors of Blue Owl Technology Finance Corp. II Who Received Shares of Blue Owl Technology Finance Corp. (NYSE: OTF), to Contact the Firm

SAN FRANCISCO, May 27, 2026 (GLOBE NEWSWIRE) — Girard Sharp, LLP, a national investment, securities, and class action firm, announces an investigation of potential securities claims on behalf of:

(1) Former Blue Owl Capital Corp. III (“Blue Owl Capital III”) investors who received shares of Blue Owl Capital Corp. (“Blue Owl Capital”) in connection with Blue Owl Capital’s merger with Blue Owl Capital III on January 13, 2025
(2) Former Blue Owl Technology Finance Corp. II (“Blue Owl Technology II”) investors who received shares of Blue Owl Technology Finance Corp. (“Blue Owl Technology”) in connection with Blue Owl Technology’s merger with Blue Owl Technology II on March 24, 2025.

Blue Owl Capital describes itself as “a specialty finance company focused on lending to U.S. middle-market companies.” Similarly, Blue Owl Technology describes itself as “a specialty finance company focused on making debt and equity investments to U.S. technology-related companies, with a strategic focus on software.” Both Blue Owl funds are externally managed by affiliates of Blue Owl Capital, Inc. (NYSE: OWL).

Since January 13, 2025, the date on which Blue Owl Capital issued shares to former Blue Owl Capital III stockholders, Blue Owl Capital’s share price has declined by over 21%. And since June 13, 2025, the date on which Blue Owl Technology listed its shares on the NYSE, Blue Owl Technology’s share price has declined by over 30%.

Girard Sharp’s investigation focuses on whether there may have been undisclosed issues with the Blue Owl funds’ investment portfolios.

If you are a former investor of Blue Owl Capital III or Blue Owl Technology II and would like to discuss your claim, please

fill out our contact form

, email

[email protected]

or call (866) 981-4800 for a free consultation.

Why Girard Sharp?

Girard Sharp represents investors, consumers, and institutions in class actions and other complex litigation nationwide. We serve on the Plaintiffs’ executive committee in the recent spoofing litigation against JPMorgan Chase that settled for $60 million, a favorable resolution that the district court preliminarily approved in December 2021. Our attorneys have obtained multimillion-dollar recoveries for victims of unfair and deceptive practices in antitrust, financial fraud, and consumer protection matters against some of the country’s largest corporations, including Raymond James, John Hancock, and Sears. Girard Sharp has earned top-tier rankings from U.S. News and World Report for Securities and Class Action Litigation and has been repeatedly selected as an Elite Trial Lawyers finalist by the National Law Journal.

Contact

Girard Sharp LLP

(866) 981-4800

[email protected]

www.girardsharp.com

May 27, 2026 6:05 am

Gran Tierra Energy Inc. Announces Completion of Conditions Precedent for Tisquirama Contract

CALGARY, Alberta, May 27, 2026 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE)(TSX:GTE)(LSE:GTE) is pleased to announce today that the Company has satisfied all outstanding conditions precedent to the effectiveness of the contract previously announced on March 17, 2026 with Ecopetrol S.A., by which the Company will earn a 49 percent working interest in the Tisquirama block located in the Middle Magdalena Valley Basin of Colombia (the “Block”), which contains the Tisquirama and San Roque fields (the “Fields”) (the “Tisquirama Contract”). Production is expressed in barrels of oil equivalent (“boe”) per day (“boepd”). All dollar amounts are in United States (“U.S.”) dollars unless otherwise indicated.

The Tisquirama Contract provides Gran Tierra with the opportunity to apply its proven waterflood expertise and operational model to assets with significant original oil in place (“OOIP”) that have historically seen limited secondary recovery and relatively low recovery factors. The Fields are adjacent to Gran Tierra’s operated Acordionero field and share similar geological characteristics, creating the potential for operational synergies and integrated field development.

Under the terms of the Tisquirama Contract, Gran Tierra is expected to focus initial Phase 1 capital activity on waterflood expansion from the Company’s operated Acordionero field into the adjoining Fields before accelerating development through wellbore optimization and low-risk infill drilling. Completion of Phase 1 is achieved with a minimum of $15 million of gross capital expenditures and implementation of continuous water injection, which is currently anticipated to be achieved in the first quarter of 2027, subject to approval of the corresponding plans by the executive committee. Upon completion of Phase 1, Gran Tierra will receive 49 percent of existing base production in addition to 49 percent of incremental production. The Fields averaged approximately 2,500 boepd on a gross basis during 2025.

Gran Tierra expects the Tisquirama Contract to create meaningful operational synergies with Acordionero, including integrated water management, the potential implementation of gas-to-power projects utilizing natural gas production in the area, and the opportunity to manage the Fields as a single operating hub to improve efficiency and maximize long-term value.

Contact Information

For investor and media inquiries please contact:
Gary Guidry, Chief Executive Officer
Ryan Ellson, Executive Vice President & Chief Financial Officer
+1(403)265-3221
[email protected]

About Gran Tierra Energy Inc.

Gran Tierra Energy Inc., together with its subsidiaries, is an independent international energy company currently focused on oil and natural gas exploration and production in Canada, Colombia, Ecuador and Azerbaijan. The Company is currently developing its existing portfolio of assets in Canada, Colombia and Ecuador; however, we have recently entered into an exploration, development and production sharing agreement with the State Oil Company of the Republic of Azerbaijan (“SOCAR”) and may eventually expand our operations into Azerbaijan and will continue to pursue additional new growth opportunities that would further strengthen the Company’s portfolio. The Company’s common stock trades on the NYSE American, the Toronto Stock Exchange and the London Stock Exchange under the ticker symbol GTE. Additional information concerning Gran Tierra is available at www.grantierra.com. Except to the extent expressly stated otherwise, information on the Company’s website or accessible from our website or any other website is not incorporated by reference into and should not be considered part of this press release. Investor inquiries may be directed to [email protected] or (403) 265-3221.

Gran Tierra’s filings with the U.S. Securities and Exchange Commission (the “SEC”) are available on the SEC website at http://www.sec.gov. Gran Tierra’s Canadian securities regulatory filings are available on SEDAR+ at http://www.sedarplus.ca and UK regulatory filings are available on the National Storage Mechanism website at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Forward Looking Statements and Legal Advisories:

This press release contains opinions, forecasts, projections, and other statements about future events or results that constitute forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and financial outlook and forward looking information within the meaning of applicable Canadian securities laws (collectively, “forward-looking statements”), which can be identified by such terms as “expect,” “plan,” “anticipate,” “target,” “outlook,” “can,” “will,” “should,” “guidance,” “estimate,” “forecast,” “signal,” “measures taken to” and “believes,” derivations thereof and similar terms identify forward-looking statements. Such forward-looking statements include, but are not limited to, statements regarding the satisfaction of the conditions precedent to, and the timing of the effectiveness of, the Contract, including receipt of regulatory approvals from the SIC; Gran Tierra’s ability to earn its working interest in the Block; the expected timing, cost and scope of the committed work program and Phase 1 capital activities, including the capital carry and social investment; the expected timing of obtaining operatorship and entitlement to base production; the expected allocation of capital and operating expenditures following completion of the Phase 1 carry commitment; OOIP relating to the Block and the Acordionero field, planned waterflood expansion, drilling, development and water injection activities; potential production levels, recovery factors and development potential; the potential use of multi-leg horizontal drilling techniques; and anticipated operational synergies, including water management integration and the potential use of natural gas to support gas-to-power infrastructure.

The forward-looking statements contained in this press release reflect several material factors and expectations and assumptions of Gran Tierra including, without limitation, that Gran Tierra will obtain the required regulatory approvals and satisfy the conditions precedent for the Contract to become effective, that Gran Tierra will continue to conduct its operations in a manner consistent with its current expectations, the accuracy of testing and production results and seismic data, pricing and cost estimates (including with respect to commodity pricing and exchange rates), rig availability, the effects of drilling down-dip, the effects of waterflood and multi-stage fracture stimulation operations, the extent and effect of delivery disruptions, and the general continuance of current or, where applicable, assumed operational, regulatory and industry conditions in Canada, Colombia, Ecuador and Azerbaijan and areas of potential expansion, and the ability of Gran Tierra to execute its business and operational plans in the manner currently planned. Gran Tierra believes the material factors, expectations and assumptions reflected in the forward-looking statements are reasonable at this time, but no assurance can be given that these factors, expectations and assumptions will prove to be correct.

Among the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements in this press release are: certain of Gran Tierra’s operations are located in South America and the Company is pursuing activities in other international jurisdictions, including Azerbaijan, and unexpected problems can arise due to guerilla activity, strikes, local blockades or protests, civil unrest, sanctions-related restrictions, or other political instability; technical difficulties and operational difficulties may arise which impact the production, transport or sale of Gran Tierra’s products; other disruptions to local operations; global and regional changes in the demand, supply, prices, differentials or other market conditions affecting oil and natural gas, including inflation and changes resulting from a global health crisis, geopolitical events, including the ongoing conflicts in Ukraine, the Middle East and Venezuela, or from the imposition or lifting of crude oil production quotas or other actions that might be imposed by OPEC and other producing countries and resulting company or third-party actions in response to such changes; changes in commodity prices, including volatility or a prolonged decline in these prices relative to historical or future expected levels; the risk that current global economic and credit conditions may impact oil and natural gas prices and oil and natural gas consumption more than Gran Tierra currently predicts, which could cause Gran Tierra to further modify its strategy and capital spending program; prices and markets for oil and natural gas are unpredictable and volatile; the effect of hedges, the accuracy of productive capacity of any particular field; geographic, political and weather conditions can impact the production, transport or sale of Gran Tierra’s products; the ability of Gran Tierra to execute its business plan, which may include acquisitions, and realize expected benefits from current or future initiatives; the risk that unexpected delays and difficulties in developing currently owned properties may occur; the ability to replace reserves and production and develop and manage reserves on an economically viable basis; the accuracy of testing and production results and seismic data, pricing and cost estimates (including with respect to commodity pricing and exchange rates); the risk profile of planned exploration activities; the effects of drilling down-dip; the effects of waterflood and multi-stage fracture stimulation operations; the extent and effect of delivery disruptions, equipment performance and costs; actions by third parties; the timely receipt of regulatory or other required approvals for Gran Tierra’s operating activities; the failure of exploratory drilling to result in commercial wells; unexpected delays due to the limited availability of drilling equipment and personnel; volatility or declines in the trading price of Gran Tierra’s common stock or bonds; the risk that Gran Tierra does not receive the anticipated benefits of government programs, including government tax refunds; Gran Tierra’s ability to comply with financial covenants in its credit agreement and indentures and make borrowings under its credit agreement; and the risk factors detailed from time to time in Gran Tierra’s periodic reports filed with the SEC, including, without limitation, under the caption “Risk Factors” in Gran Tierra’s Annual Report on Form 10-K for the year ended December 31, 2025 filed on March 4, 2026 and its other filings with the SEC. These filings are available on the SEC’s website at http://www.sec.gov and on SEDAR+ at www.sedarplus.ca and UK regulatory filings are available on the National Storage Mechanism website at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

The forward-looking statements contained in this press release are based on certain assumptions made by Gran Tierra based on management’s experience and other factors believed to be appropriate. Gran Tierra believes these assumptions to be reasonable at this time, but the forward-looking statements are subject to risks and uncertainties, many of which are beyond Gran Tierra’s control, which may cause actual results to differ materially from those implied or expressed by the forward looking statements. The risk that the assumptions on which the 2026 outlook are based prove incorrect may increase the later the period to which the outlook relates. All forward-looking statements are made as of the date of this press release and the fact that this press release remains available does not constitute a representation by Gran Tierra that Gran Tierra believes these forward-looking statements continue to be true as of any subsequent date. Actual results may vary materially from the expected results expressed in forward-looking statements. Gran Tierra disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. In addition, historical, current and forward-looking sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. Gran Tierra’s forward-looking statements are expressly qualified in their entirety by this cautionary statement.

Presentation of Oil and Gas Information

Boes have been converted on the basis of six thousand cubic feet (“Mcf”) natural gas to 1 boe of oil. Boes may be misleading, particularly if used in isolation. A boe conversion ratio of 6 Mcf: 1 boe is based on an energy equivalency conversion method primarily applicable at the burner tip and does not represent a value equivalency at the wellhead. In addition, given that the value ratio based on the current price of oil as compared with natural gas is significantly different from the energy equivalent of six to one, utilizing a boe conversion ratio of 6 Mcf: 1 boe would be misleading as an indication of value.

References to a formation where evidence of hydrocarbons has been encountered is not necessarily an indicator that hydrocarbons will be recoverable in commercial quantities or in any estimated volume. Gran Tierra’s reported production is a mix of light crude oil and medium heavy crude oil, tight oil, conventional natural gas, shale gas and natural gas liquids for which there is no precise breakdown since the Company’s sales volumes typically represent blends of more than one product type. Well test results should be considered as preliminary and not necessarily indicative of long-term performance or of ultimate recovery. Well log interpretations indicating oil and gas accumulations are not necessarily indicative of future production or ultimate recovery. If it is indicated that a pressure transient analysis or well-test interpretation has not been carried out, any data disclosed in that respect should be considered preliminary until such analysis has been completed. References to thickness of “oil pay” or of a formation where evidence of hydrocarbons has been encountered is not necessarily an indicator that hydrocarbons will be recoverable in commercial quantities or in any estimated volume.

May 27, 2026 6:03 am

Platoon Aviation’s Fleet Will Expand Charter Operations to Become Europe’s Largest Cessna Citation Longitude Fleet

Platoon Aviation’s Fleet Will Expand Charter Operations to Become Europe’s Largest Cessna Citation Longitude Fleet

WICHITA, Kan.–(BUSINESS WIRE)–Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced it has entered into a multi-aircraft fleet purchase agreement with Platoon Aviation that positions the Hamburg-based charter operator to become the largest Cessna Citation Longitude fleet owner in Europe. Platoon Aviation provides on-demand private jet travel, serving business and leisure travelers seeking long-range capability, cabin comfort and operational reliability. Deliveries of the Citation Longitude aircraft are expected to begin in 2027.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260527805306/en/

Platoon Aviation’s fleet will expand charter operations to become Europe’s largest Cessna Citation Longitude fleet. (Photo credit: Textron Aviation)

“From performance and cabin experience to the strength of our global support network, the Citation Longitude provides charter operators with the confidence to grow their fleets and serve customers at the highest level,” said Lannie O’Bannion, senior vice president, Sales & Marketing, Textron Aviation. “This agreement with Platoon Aviation underscores the Longitude’s leadership in the super-midsize segment and the trust customers place in Cessna and our team.”

As the flagship of the Citation family, the Citation Longitude is designed around the needs of both pilots and passengers, delivering advanced avionics, efficient operating economics and a refined in-flight experience. The business jet is well suited for European charter operations, offering the range and performance to connect key business corridors nonstop, including routes such as Hamburg to Madrid and London to Athens. The aircraft features the quietest cabin in the super-midsize class, a flat-floor stand-up cabin measuring 1.83 meters, seating for up to 12 passengers and class-leading legroom.

“Platoon Aviation is redefining what business aviation can look like in the next decade,” said Deniz Weißenborn, CEO, Platoon Aviation. “The Citation Longitude fleet expansion reflects our commitment to building a future-proof, next-generation aviation platform that combines operational efficiency, sustainability and uncompromising comfort. The aircraft position us to meet the evolving expectations of modern travelers while giving our clients greater flexibility, reliability and connectivity across Europe and beyond.”

Textron Aviation delivers comprehensive global aftermarket service and support for Cessna and Beechcraft customers, providing complete life-cycle support wherever aircraft operate. For an expanding European charter operator like Platoon Aviation, this support is enabled by a strong regional footprint that includes five company-owned service centers, a network of Authorized Service Facilities (ASFs) and mobile service support teams, ensuring responsive, expert care across the region. European operators also benefit from the company’s European Parts Distribution Center (EUDC), providing fast shipping, reliable access to genuine parts and dedicated in-region support. Backed by 24/7 Aircraft-on-Ground (AOG) assistance, this integrated support network helps Platoon Aviation maximize fleet availability and maintain the high utilization required to reliably serve customers across Europe.

About the Cessna Citation Longitude

With a range of 6,482 kilometers (3,500 nautical miles) and full fuel payload of 726 kilograms (1,600 pounds), the Citation Longitude offers customers a low cabin altitude (1,509 meters / 4,950 feet) at 12,500 meters/ 41,000 feet, more standard features and a comfortable, bespoke interior. The aircraft features fully berthable seats and a spacious walk-in baggage compartment that is accessible throughout the flight. The spacious cockpit incorporates easier access and an ergonomic design that fully focuses on crew comfort and efficiency.

The clean-sheet design of the Longitude integrates the latest technology throughout the aircraft, bringing customers the lowest direct operating cost in its class. Powered by FADEC-equipped Honeywell HTF7700L turbofan engines, the Longitude combines on-condition engine overhaul periods to best-in-class airframe inspection intervals of 18 months and 800 hours. Textron Aviation’s full-time diagnostics recording system (LinxUs) and 3D Technical Publications leverage advanced technology to reduce maintenance downtime and overall costs to operation.

For more information about the Citation Longitude, visit https://cessna.txtav.com/en/citation/longitude.

About Textron Aviation Inc.

We have been inspiring the journey of flight for nearly 100 years. Textron Aviation Inc., a Textron Inc. company, has empowered our collective talent across the Beechcraft, Cessna, Hawker and Pipistrel brands to design and deliver the best aviation experience for our customers. With a range that includes everything from business jets, turboprops, light and high-performance pistons, to special mission, military trainer and defense aircraft, Textron Aviation has the most versatile and comprehensive aviation product portfolio in the world and a workforce that has produced more than half of all general aviation aircraft worldwide. Customers in more than 170 countries rely on our legendary performance, reliability and versatility, along with our trusted global customer service network, for affordable, productive and flexible flight. For more information, visit www.txtav.com.

About Textron Inc.

Textron Inc. is a multi-industry company that leverages its global network of aircraft, defense, industrial and finance businesses to provide customers with innovative solutions and services. Textron is known around the world for its powerful brands such as Bell, Cessna, Beechcraft, Pipistrel, Jacobsen, Kautex, Lycoming, E-Z-GO, and Textron Systems. For more information, visit: www.textron.com.

Certain statements in this press release may project revenues or describe strategies, goals, outlook or other non-historical matters; these forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update them. These statements are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements, including, but not limited to changes in aircraft delivery schedules or cancellations or deferrals of orders.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260527805306/en/

Media Contact

Kate Flavin

+1.316.252.7780

[email protected]

txtav.com

KEYWORDS: Europe United States North America Kansas

INDUSTRY KEYWORDS: Air Transport Aerospace Manufacturing

MEDIA:

Photo

Platoon Aviation’s fleet will expand charter operations to become Europe’s largest Cessna Citation Longitude fleet. (Photo credit: Textron Aviation)

Logo

May 27, 2026 5:33 am

Weibo Announces Results of 2026 Annual General Meeting

PR Newswire

BEIJING, May 27, 2026 /PRNewswire/ — Weibo Corporation (“Weibo” or the “Company”) (NASDAQ: WB and HKEX: 9898), a leading social media in China, today announced that the following proposed resolutions submitted for shareholder approval as set forth in the notice of annual general meeting dated April 13, 2026 have been adopted at its 2026 annual general meeting of shareholders held today:

as an ordinary resolution, THAT Mr. Charles Guowei Chao shall be re-elected as a director of the Company at this annual general meeting and retain office until his retirement pursuant to the Company’s memorandum and articles of association;
as an ordinary resolution, THAT Mr. Gaofei Wang shall be re-elected as a director of the Company at this annual general meeting and retain office until his retirement pursuant to the Company’s memorandum and articles of association; and
as an ordinary resolution, THAT Mr. Pochin Christopher Lu shall be re-elected as a director of the Company at this annual general meeting and retain office until his retirement pursuant to the Company’s memorandum and articles of association.

About Weibo

Weibo is a leading social media for people to create, share and discover content online. Weibo combines the means of public self-expression in real time with a powerful platform for social interaction, content aggregation and content distribution. Any user can create and post a feed and attach multi-media and long-form content. User relationships on Weibo may be asymmetric; any user can follow any other user and add comments to a feed while reposting. This simple, asymmetric and distributed nature of Weibo allows an original feed to become a live viral conversation stream.

Weibo enables its advertising and marketing customers to promote their brands, products and services to users. Weibo offers a wide range of advertising and marketing solutions to companies of all sizes. Weibo generates a substantial majority of its revenues from the sale of advertising and marketing services, including the sale of social display advertisement and promoted marketing offerings. Weibo displays content in a simple information feed format and offers native advertisement that conforms to the information feed on our platform. We are continuously refining our social interest graph recommendation engine, which enables our customers to perform people marketing and target audiences based on user demographics, social relationships, interests and behaviors, to achieve greater relevance, engagement and marketing effectiveness.

Contact:

Investor Relations
Weibo Corporation
Phone: +86 10 5898-3336
Email: [email protected]

View original content:https://www.prnewswire.com/news-releases/weibo-announces-results-of-2026-annual-general-meeting-302782919.html

SOURCE Weibo Corporation

May 27, 2026 5:04 am

Colliers completes acquisition of Ayesa Engineering

TORONTO, May 27, 2026 (GLOBE NEWSWIRE) — Colliers (NASDAQ, TSX: CIGI), a global leader in professional services and investment management, announced today it has completed its previously announced acquisition of Ayesa Engineering S.A.U. (“Ayesa Engineering” or “Ayesa”), the engineering division of Ayesa Inversiones S.L.U. (“Ayesa Group”). Ayesa Engineering is a global multidiscipline engineering and project management firm headquartered in Seville, Spain, that provides technical consulting services across four continents. Ayesa’s leadership team has retained significant equity under Colliers’ unique partnership model and will drive the operations and growth of the business going forward.

With the addition of Ayesa Engineering’s more than 3,300 professionals, Colliers’ Engineering segment (“Colliers Engineering”) now operates in 23 countries with over 11,000 professionals, firmly establishing Colliers Engineering as a leading global consultancy delivering engineering, design, project management, and other technical consulting services across Property & Buildings, Infrastructure & Transportation, Water, and Environmental end markets.

“Ayesa is a highly strategic acquisition that meaningfully expands the global scale of our engineering business, strengthens the resilience of our earnings, and underscores the power of our partnership model,” said Jay Hennick, Global Chairman and Chief Executive Officer of Colliers. “Our ability to partner with exceptional operators and align them for long-term growth differentiates Colliers. More than 700 of our operators are partners in our engineering business, creating strong alignment, reinforcing our entrepreneurial culture, and driving long-term value creation. Looking ahead, we see significant opportunity to accelerate global growth within our engineering business, both organically and through acquisitions.”

“This acquisition strengthens our ability to serve clients in attractive, high-growth markets across Europe, Latin America, the Middle East and South Asia, while broadening our technical capabilities on a global scale,” said Elias Mulamoottil, Chief Investment Officer and CEO of Engineering at Colliers. “That expertise is reflected in Ayesa’s complex, high-profile projects such as the design and project oversight of the transformation of the Santiago Bernabéu Stadium in Madrid, the design of hundreds of desalination and water distribution facilities across Saudi Arabia, and the design and project oversight of several metro lines globally including the Bogotá Metro in Colombia.”

“Partnering with Colliers creates an exceptional opportunity for our professionals to become significant stakeholders in the business, reinforcing long-term stability and our focus on delivering the best outcomes for clients,” said Rosalío Alonso, Chief Executive Officer of Ayesa Engineering. “It also gives us the ability to leverage Colliers’ significant engineering operations in the U.S., Canada, and Australia, while benefiting from its more than 30-year track record of scaling global businesses and creating long-term value for all stakeholders.”

In connection with the transaction, Alantra acted as financial advisor and Uría Menéndez acted as legal advisor to Colliers. Baird and Arcano Partners acted as financial advisors and Pérez-Llorca and Weil, Gotshal & Manges acted as legal advisors to Ayesa Group and its owners, A&M Capital Europe and the Manzanares family.

Colliers Contacts
Elias Mulamoottil
Chief Investment Officer & CEO, Engineering

Christian Mayer
Chief Financial Officer & CEO, Commercial Real Estate

(416) 960-9500

About Colliers

Colliers (NASDAQ, TSX: CIGI) is a global diversified professional services and investment management company operating through three industry-leading businesses: Commercial Real Estate, Engineering, and Investment Management. With greater than a 30-year track record of consistent growth and strong recurring cash flows, we scale complementary, high-value businesses that provide essential services across the full asset lifecycle. Our unique partnership philosophy empowers exceptional leaders, preserves our entrepreneurial culture, and ensures meaningful inside ownership — driving strong alignment and sustained value creation for our shareholders. With $5.7 billion in annual revenues, 24,000 professionals, and $109 billion in assets under management, Colliers is committed to accelerating the success of our clients, investors, and people worldwide. Learn more at corporate.colliers.com.

About Ayesa Engineering
Ayesa Engineering is a leading multidisciplinary engineering and project management firm headquartered in Spain. With approximately 3,300 professionals operating in 21 countries, the company delivers innovative design, site supervision, and consultancy services across transportation, water, buildings & cities, and energy sectors. Ayesa Engineering is recognized for its technical excellence and ability to manage complex infrastructure projects for both public and private clients. Its approach combines deep sector expertise with a commitment to sustainability and cutting-edge solutions, making it a trusted partner in shaping the future of global infrastructure. For more information, visit http://www.ayesa.com.

May 27, 2026 4:42 am

Pinterest, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – PINS

PR Newswire

LOS ANGELES, May 27, 2026 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against Pinterest, Inc. (“Pinterest” or “the Company”) (NYSE: PINS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of PINS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: February 7, 2025 to February 12, 2026

DEADLINE: May 29, 2026

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Pinterest suffered from reduced revenues derived from advertising partners. The Company misled investors about its ability to manage U.S. tariffs. Based on these facts, Pinterest’s public statements were false and materially misleading throughout the class period.

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group’s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

Join the case to recover your losses.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]

View original content:https://www.prnewswire.com/news-releases/pinterest-inc-sued-for-securities-law-violations—contact-the-djs-law-group-to-discuss-your-rights–pins-302782569.html

SOURCE DJS Law Group LLP

May 27, 2026 2:35 am

Aligos Therapeutics Presents Positive Data at the EASL Congress 2026

Long-term follow up data from the Phase 1 study of pevifoscorvir sodium continues to suggest a reduction in the cccDNA reservoir
Data on the preclinical characteristics of the Aligos/Amoytop ASO program to be presented
40% of HBeAg+ participants with chronic HBV infection treated with pevifoscorvir sodium at week 48 had reductions in HBsAg that would potentially allow them to qualify for ASO treatment

SOUTH SAN FRANCISCO, Calif., May 27, 2026 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced positive data from ten presentations at the European Association for the Study of the Liver (EASL) Congress 2026, being held May 27 – 30, 2026 in Barcelona, Spain.

“We are pleased to present positive data, including an investigator led study of ≥24 week follow up in HBeAg+ participants with nucleos(t)ide analogs (NAs) after 96 weeks of pevifoscorvir sodium monotherapy, which further supports our belief that we are reducing the cccDNA reservoir by activating the secondary mechanism of CAM-Es. By accessing this mechanism, we are also reducing HBsAg to a level that may allow additional patients to be eligible for functional cure therapy, including the ASO ALG-170675, being developed by Aligos and partner Amoytop,” stated Lawrence Blatt, Ph.D., M.B.A., Chairman, President, and Chief Executive Officer of Aligos Therapeutics. “Further, we will present data demonstrating that the combination of pevifoscorvir sodium and our antisense oligonucleotide ALG-170675 showed an additive to synergistic effects on reductions in HBV viral markers. Taken together, these data signal that pevifoscorvir sodium has the potential to not only replace NAs as the standard of care for chronic HBV infection but play a meaningful part in a functional cure regimen.”

Pevifoscorvir Sodium Post Treatment Data

Newly presented data highlight outcomes for treatment-naïve or currently not treated HBeAg+ subjects who completed 96 weeks of 300 mg pevifoscorvir sodium monotherapy, followed by ≥24 weeks of nucleos(t)ide analog (NA) monotherapy. Among HBeAg+ subjects, 9 of 10 subjects transitioned to NA monotherapy; of these, 4 (44%) maintained HBV DNA levels below the lower limit of quantification (LLOQ; 10 IU/mL, target detected [TD] or target not detected [TND]) throughout the NA only ≥24 week follow-up period. Reductions in HBV antigens and HBV RNA were maintained during the NA only ≥24 week follow-up period. Notably, these viral biomarkers, such as HBV antigens and HBV RNA, are typically unaffected by NA therapy, suggesting that pevifoscorvir sodium may reduce the cccDNA reservoir through engagement of its secondary mechanism of action.

In addition, newly presented data showed that among participants with a baseline HBsAg ≥3,000 IU/mL, 40% (4/10) achieved HBsAg <3,000 IU/mL at 48 weeks, suggesting eligibility for a functional cure regimen, which may include an antisense oligonucleotide (ASO) agent. In clinical trials conducted to date, certain ASO agents under development for chronic HBV infection have seen 20-30% functional cure rates in a patient population of HBsAg <3,000 IU/mL.

Additionally, preclinical in vitro data demonstrated that long-term treatment with ALG-001075, the active parent moiety of pevifoscorvir sodium, resulted in profound suppression of HBeAg, HBsAg and intracellular HBV RNAs which was durable after treatment withdrawal in HBV-infected HepaRG cells, suggesting a potential reduction in cccDNA level and/or transcriptional activity.

Preclinical Data

The preclinical posters showcased Aligos’ and its collaborators’ continued innovation and commitment to advancing next-generation therapies in the liver and viral spaces with presentations spanning novel approaches and mechanistic insights.

In particular, an analog of ALG-170675, a potential best-in-class antisense oligonucleotide (ASO), demonstrated an additive to synergistic effect when combined in vitro and in vivo with ALG-001075, the active parent moiety of pevifoscorvir sodium.

Additionally, in vitro data from the hepatitis delta virus (HDV) program demonstrates how the novel approach of targeting HDV replication could be a valuable addition to the current therapeutic arsenal.

Details on the presentations are as follows:

Pevifoscorvir sodium: Potential first-/best-in-class small molecule CAM-E for chronic hepatitis B

virus (HBV) infection

Abstract #: 588
Title: Sustained reduction of HBV antigen levels at ≥6 months follow-up in HBeAg-positive participants with chronic hepatitis B infection after 96 weeks of 300 mg pevifoscorvir sodium monotherapy
Presenter: Professor Lung-Yi Mak, MBBS(HK), MD(HK), MRCP(UK), PDipID (HK), FHKCP, FHKAM (Medicine), FRCP (Glasg), FRCP (Edin), FRCP, Clinical Assistant Professor at The University of Hong Kong
Date/Time: May 27, 2026 at 8:30am – 5:00pm CET
Session: Poster Tour – Track 8 – Viral Hepatitis; Viral Hepatitis B and D: New therapies, unapproved therapies or strategies

Abstract #: 602
Title: Pevifoscorvir sodium demonstrated profound antiviral activity in untreated HBeAg+ subjects, regardless of baseline ALT level
Presenter: Professor Man-Fung Yuen, MBBS, MD, PhD, DSc, Chair and Chief of the Division of Gastroenterology and Hepatology, University of Hong Kong
Date/Time: May 27, 2026 at 8:30am – 5:00pm CET
Session: Poster Tour – Track 8 – Viral Hepatitis; Viral Hepatitis B and D: New therapies, unapproved therapies or strategies

Abstract #: 586
Title: Population pharmacokinetics of pevifoscorvir sodium (ALG-000184) in healthy participants and participants with chronic hepatitis B in support of phase 2 dose selection
Presenter: Kha Le, PhD
Date/Time: May 27, 2026 at 8:30am – 5:00pm CET
Session: Viral Hepatitis B and D: New therapies, unapproved therapies or strategies

Abstract #: 570
Title: ALG-001075, the parent of pevifoscorvir sodium, exhibits potent in vitro antiviral properties compared to other HBV capsid assembly modulators in clinical development
Presenter: Yannick Debing, PhD
Date/Time: May 28, 2026 at 8:30am – 5:00pm CET
Session: Viral Hepatitis: Experimental and pathophysiology

Abstract #: 634
Title: Potent and durable off-treatment reduction of HBsAg levels and cccDNA-derived transcripts by the CAM-E ALG-001075 in cell-based experiments
Presenter: Professor Barbara Testoni, PhD, HDR, DR2 INSERM – Team Leader “Hepatitis Viruses and Liver pathogenesis”. Université Claude Bernand Lyon 1, Inserm UMR 1350 – PaThLiv
Date/Time: May 28, 2026 at 8:30am – 5:00pm CET
Session: Viral Hepatitis: Experimental and pathophysiology

ALG-170675: Potential best-in-class antisense oligonucleotide (ASO) for chronic hepatitis B virus (HBV) infection

Abstract #: 587
Title: The potentially best-in-class HBV ASO ALG-170674 demonstrates additive to synergistic antiviral activities when combined with other anti-HBV modalities
Presenter: Jin Hong, PhD
Date/Time: May 28, 2026 at 8:30am – 5:00pm CET
Session: Viral Hepatitis: Experimental and pathophysiology

ALG-055009: Potential best-in-class small molecule THR-

β

Agonist for Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Abstract #: 184
Title: Synergistic fat mass loss in diet-induced obese mice when thyroid hormone receptor-β agonist ALG-055009 was administered in combination with incretin receptor agonists
Presenter: Xuan Luong, PhD
Date/Time: May 30, 2025 at 8:30am – 4:00pm CET
Session: Poster – MASLD: Experimental and pathophysiology

Preclinical

Abstract #: 606
Title: Antisense oligonucleotide-based strategy to target hepatitis delta virus infections
Presenter: Julie Lucifora, PhD, HDR, Director of Research, INSERM, CIRI – Centre International de Recherche en Infectiologie
Date/Time: May 28, 2026 at 12:45 – 1:45pm CET; May 28, 2026 at 8:30am – 5:00pm CET
Session: Poster Tour – Track 8 – Viral Hepatitis; Viral Hepatitis: Experimental and pathophysiology

Abstract #: 610
Title: Discovery of novel HDV entry inhibitors with selectivity over bile acid inhibition
Presenter: David McGowan, MS
Date/Time: May 28, 2026 at 8:30am – 5:00pm CET
Session: Viral Hepatitis: Experimental and pathophysiology

Abstract #: 620
Title: Preclinical characterization of ALG-093940, a potent and orally bioavailable small molecule PD-1/PD-L1 inhibitor for the treatment of chronic hepatitis B infection and liver cancer
Presenter: Heleen Roose, PhD
Date/Time: May 28, 2026 at 8:30am – 5:00pm CET
Session: Viral Hepatitis: Experimental and pathophysiology

The presentations can be found on the Posters & Presentations section of the Aligos website (www.aligos.com) after the live event.

About Aligos

Aligos Therapeutics, Inc. (NASDAQ: ALGS) is a clinical stage biotechnology company founded with the mission to improve patient outcomes by developing best-in-class therapies for the treatment of liver and viral diseases. Aligos applies its science driven approach and deep R&D expertise to advance its purpose-built pipeline of therapeutics for high unmet medical needs such as chronic hepatitis B virus infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronaviruses.

For more information, please visit www.aligos.com or follow us on LinkedIn or X.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this press release that are not historical facts may be considered “forward-looking statements,” including without limitation, statements regarding Aligos’ financial results and performance as well as research and development activities, including regulatory status and the timing of announcements and updates relating to our regulatory filings and clinical trials; statements about the potential benefits of pevifoscorvir sodium including its potential to replace NAs as the standard of care for chronic HBV infection and be part of a functional cure regimen, and whether the B-SUPREME study will show superiority of pevifoscorvir sodium over NAs; statements about whether pevifoscorvir sodium will be shown to reduce the cccDNA reservoir; and statements about the potential benefits of combining pevifoscorvir sodium with an ASO agent. Such forward looking statements are subject to substantial risks and uncertainties that could cause our development programs, future results, performance, or achievements to differ materially from those anticipated in the forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties inherent in the drug development process, including Aligos’ clinical-stage of development, the process of designing and conducting clinical trials, the regulatory approval processes, and other matters that could affect the sufficiency of Aligos’ capital resources to fund operations. For a further description of the risks and uncertainties that could cause actual results to differ from those anticipated in these forward-looking statements, as well as risks relating to the business of Aligos in general, see Aligos’ Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 7, 2026 and its future periodic reports to be filed or submitted with the Securities and Exchange Commission. Except as required by law, Aligos undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances, or to reflect the occurrence of unanticipated events.

Investor Contact

Aligos Therapeutics, Inc.
Jordyn Tarazi
Vice President, Investor Relations & Corporate Communications
+1 (650) 910-0427
[email protected]

Media Contact

Inizio Evoke
Jake Robison
Vice President
[email protected]